Non Alcoholic Fatty Liver Disease: Clinical Trials

39 trials for Non Alcoholic Fatty Liver Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

25 completed, 8 unknown, 2 terminated, 1 enrolling by invitation. 20 Not applicable, 8 Phase 2, 2 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable20Completed 13, Unknown 4, Not yet recruiting 1, Terminated 1, Withdrawn 1
Phase 28Completed 6, Terminated 1, Unknown 1
Phase 32Completed 2
Phase 41Unknown 1

Follow Non Alcoholic Fatty Liver Disease: new trials by email Literature Review of Non Alcoholic Fatty Liver Disease trials Research Report on Non Alcoholic Fatty Liver Disease

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Impact of Artificial Intelligence Algorithm-driven Versus Standard Lifestyle Intervention in Non-Alcoholic Fatty Liver Disease - A Multicenter, Randomized, Open-label, Controlled Trial
Fibroscan CAP/VTE, Randomization, MRI-PDFF - Non Alcoholic Fatty Liver Disease
Not applicableNot yet recruitingUniversity Hospital, Toulouse2162026-06-012026-03-27
Cardiovascular Risk in Children With Chronic Conditions Study
Kidney Transplant, Familial Hypercholesterolaemia
RecruitingSemmelweis University3002025-04-012025-08-08
Relationship Between Eating Patterns, Body Composition and the Detection of Fatty Liver in Children and Adolescents With Trisomy 21: LiverTy Project
To evaluate fat liver content in the cases/controls population. - Obesity Prevention, Pediatric Obesity
Enrolling by invitationIMDEA Food342025-03-012025-05-02
Effects of Turkish Coffee and Green Tea in Fatty Liver Disease
green tea, Turkish Coffee, mediterranean diet - Non Alcoholic Fatty Liver Disease
Not applicableCompletedOkan University472024-09-252026-08-17
Comparison of Effectiveness of Obeticholic Acid With Vitamin E in Patients of Non-alcoholic Fatty Liver Disease
Obeticholic Acid 10 MG, Vitamin E 400mg - Non Alcoholic Fatty Liver Disease
Phase 2CompletedKing Edward Medical University902023-08-242025-08-05
A Digital Solution for Individuals With Non Alcoholic Fatty Liver Disease
A digital care solution for patients with NAFLD - Non Alcoholic Fatty Liver Disease
Not applicableCompletedSidekick Health382022-06-202023-04-26
UDFF Performance Evaluation ((Ultrason Derived Fat Fraction)
UDFF - Non Alcoholic Fatty Liver Disease
UnknownUniversity Hospital, Angers1002022-03-012023-10-12
Study to Investigate the Effect of L. Lactis CKDB001 Administration on Liver Aminotransferases in Subjects With NAFLD
Probiotics (L. lactis CKDB001), Placebo - Non Alcoholic Fatty Liver Disease
Not applicableCompletedChuncheon Sacred Heart Hospital952021-08-182026-01-30
Efficacy and Safety of Pemafibrate for Nonalcoholic Fatty Liver Disease
Pemafibrate high dose, Pemafibrate low dose, Fenofibrate - Non Alcoholic Fatty Liver Disease
Phase 2UnknownYokohama City University3602020-12-232024-10-02
Nicotinamide in Non-Alcoholic Fatty Liver Disease Patients
Niacinamide Oral Tablet, Antidiabetic - Non Alcoholic Fatty Liver Disease
Phase 2CompletedAin Shams University612019-01-152020-01-22
Effect of Dulaglutide on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
Dulaglutide - Non Alcoholic Fatty Liver Disease, Type2 Diabetes Mellitus
Not applicableCompletedMedanta, The Medicity, India602019-01-012020-02-20
Prevention and Reversion of NAFLD in Obese Patients With Metabolic Syndrome by Mediterranean Diet and Physical Activity
Physical activity and Mediterranean Diet (PA-MD), High meal frequency of Mediterranean Diet (HMF-MD), Control diet (CD) - Non Alcoholic Fatty Liver Disease
Not applicableUnknownUniversity of the Balearic Islands1502017-10-262020-06-22
Non Alcoholic Fatty Liver Disease: Nutritional Epidemiology and Lifestyle Medicine
Mediterranean Style - Non Alcoholic Fatty Liver Disease, Lifestyle
Not applicableCompletedUniversità degli Studi di Brescia1002017-06-132019-05-23
Mastiha Treatment for Obese With NAFLD Diagnosis
Mastiha, Placebo - Non Alcoholic Fatty Liver Disease
Not applicableCompletedHarokopio University1002017-03-082022-04-07
Safety And Efficacy Study Of Orally Administered Epeleuton In Patients With NAFLD
Placebo capsules, Epeleuton - Non Alcoholic Fatty Liver Disease
Phase 2CompletedAfimmune962016-12-202022-10-12
Effect of Empagliflozin on Liver Fat Content in Patients With Type 2 Diabetes
Empagliflozin - Non Alcoholic Fatty Liver Disease
Not applicableCompletedMedanta, The Medicity, India1002016-03-012019-08-15
Assessment of Endothelial Function in Patients With Non Alcoholic Fatty Liver Disease and the Impact of Statin Treatment
atorvastatin, lifestyle counseling - Non Alcoholic Fatty Liver Disease
Not applicableWithdrawnSheba Medical Center2015-12-012017-04-27
"Preventing Cardiovascular Ischemic Events and Arresting Their Consequences in Type 2 Diabetic Population
Type2 Diabetes Mellitus, Microangiopathy
UnknownHospital Universitari Vall d'Hebron Research Institute2602014-09-012018-01-23
The Effect of Oral β- Glucan Supplement on Appetite and Insulin Resistance in Non Alcoholic Fatty Liver Disease
β- glucan, Maltodextrin - Non Alcoholic Fatty Liver Disease
Not applicableUnknownUrmia University of Medical Sciences482014-07-012014-07-01
The Role of Obstructive Sleep Apnea in Children With Fatty Liver Disease
Continuous positive airway pressure (CPAP). - Non Alcoholic Fatty Liver Disease
Not applicableTerminatedYale University12014-06-012018-06-08

Showing 20 of 39. Sign in to see all of them.

Narrower conditions

Non-alcoholic Fatty Liver Disease (39)  ·  Diabetes Mellitus, Type 2 (4)  ·  Fatty Liver (4)  ·  Liver Cirrhosis (3)  ·  Metabolic Syndrome (3)  ·  Obesity (3)  ·  Pediatric Obesity (3)  ·  Insulin Resistance (2)  ·  Motor Activity (2)  ·  Overweight (2)  ·  Aortic Coarctation (1)  ·  Aortic Valve Stenosis (1)  ·  Cerebrovascular Disorders (1)  ·  Coronary Artery Disease (1)  ·  Diabetes Mellitus, Type 1 (1)

Broader conditions

Digestive System Diseases (39)  ·  Liver Diseases (38)  ·  Fatty Liver (35)  ·  Nutritional and Metabolic Diseases (13)  ·  Pathological Conditions, Signs and Symptoms (11)  ·  Metabolic Diseases (10)  ·  Glucose Metabolism Disorders (8)  ·  Body Weight (7)  ·  Signs and Symptoms (7)  ·  Nutrition Disorders (6)  ·  Overnutrition (6)  ·  Pathologic Processes (5)  ·  Diabetes Mellitus (4)  ·  Endocrine System Diseases (4)  ·  Hyperinsulinism (4)

Interventions

Glucose Tolerance Test (3)  ·  Continuous Positive Airway Pressure (2)  ·  Diet, Mediterranean (2)  ·  Exercise (2)  ·  (1-6)-alpha-glucomannan (1)  ·  (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid (1)  ·  Atorvastatin (1)  ·  Diet (1)  ·  Docosahexaenoic Acids (1)  ·  Fatty Acids, Omega-3 (1)  ·  Fenofibrate (1)  ·  Genotype (1)  ·  Hypoglycemic Agents (1)  ·  Lactose (1)  ·  Niacinamide (1)

Sponsors

Yale University (3)  ·  Ain Shams University (2)  ·  Medanta, The Medicity, India (2)  ·  Abbott (1)  ·  Afimmune (1)  ·  Bambino Gesù Hospital and Research Institute (1)  ·  Biovil Research Group, LLC (1)  ·  Centre Hospitalier Universitaire de Nice (1)  ·  Chuncheon Sacred Heart Hospital (1)  ·  Fundación Clínica Médica Sur (1)  ·  Harokopio University (1)  ·  Hospital Universitari Vall d'Hebron Research Institute (1)  ·  IMDEA Food (1)  ·  Imperial College London (1)  ·  Johns Hopkins University (1)

Countries

United States (7)  ·  France (4)  ·  United Kingdom (4)  ·  Italy (3)  ·  Spain (3)  ·  India (2)  ·  Israel (2)  ·  Austria (1)  ·  Denmark (1)  ·  Egypt (1)  ·  Georgia (1)  ·  Germany (1)  ·  Greece (1)  ·  Hungary (1)  ·  Iceland (1)

Top investigators

Alan R Schwartz, M.D. (1)  ·  Anders E Junker, MD, phd-student (1)  ·  Chiara Ricci, MD. PhD (1)  ·  Christoph Beglinger, MD (1)  ·  Clara Balsano, MD (1)  ·  Daniel Cuthbertson, BSc PhD MRCP (1)  ·  Elif A Oral, MD (1)  ·  Fariba Shojaee-Moradie, BSc PhD (1)  ·  Gary Frost (1)

Results publications

PMID 22431131, PMID 21094444, PMID 22025886, PMID 22554256, PMID 23383649, PMID 23398530, PMID 23906374, PMID 24742660, PMID 25018121, PMID 25482832, PMID 25532016, PMID 26089386, PMID 26555703, PMID 27439593, PMID 27583475, PMID 27732328, PMID 27916783, PMID 28323124, PMID 28550439, PMID 29506157, PMID 29665034, PMID 29895557, PMID 32652034, PMID 32779505, PMID 32865597, PMID 34025683, PMID 35222903, PMID 35585153, PMID 37107208, PMID 38035766, PMID 38152892, PMID 38303926, PMID 38847589

NIH funding

R01HD040787 (2), 2008 (1), 2016 (1)